Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Oct 1, 2014 (12 years ago)

Emtriva (emtricitabine)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Container; leaking around the cap

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc., Foster City, CA NDC 61958-0602-1 Gilead Sciences, Inc. Foster City, CA 94404.

Affected NDC 61958-0602-01

Compare with the code on your package — it is the most precise check available.

Drug: Emtricitabine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Emtriva
Emtricitabine
NDC 61958-0602
10 mg/mL Solution
Oral
Gilead Sciences, Inc. Rx
Recalling firm
Gilead Sciences, Inc.
NDC code
61958-0602-1
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0045-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Emtricitabine recalls

See all
Class III · Low risk

Atripla

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 15584-0101-1 D-1090-2014

Other recalls by Gilead Sciences, Inc.

All 2014 recalls
Class I · High risk

Veklury (remdesivir)

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 61958-2901-2 D-0299-2022
Class III · Low risk

Atripla

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 15584-0101-1 D-1090-2014